Get started
Author

Peter Masci

Observed name: P Masci
OpenAlex ID: A5060433667
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
2019 · Rachna T. Shroff, Milind M. Javle, et al. · JAMA Oncology · 468
PDF
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma
2021 · Daniel H. Ahn, Pedro Luiz Serrano Uson Junior, et al. · Investigational New Drugs · 27
A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).
2017 · Rachna T. Shroff, Mitesh J. Borad, et al. · Journal of Clinical Oncology · 14
A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs): Updated survival analysis.
2018 · Rachna T. Shroff, Milind M. Javle, et al. · Journal of Clinical Oncology · 2
A Pilot Study of Ponatinib in Patients With FGFR-Altered Advanced Cholangiocarcinoma
2021 · Daniel H. Ahn, Pedro Luiz Serrano Uson Junior, et al. · Research Square · 1
PDF
A randomised placebo controlled clinical trial assessing the efficacy and safety of supplementation with B vitamins to reduce the incidence of Chemotherapy Induced Peripheral Neuropathy [CION]
2011 · Janet Schloss, Maree Colosimo, et al.
A Pilot Clinical Trial Assessing the efficacy and Safety of supplementation with vitamin B12 and other B vitamins to reduce the incidence of chemotherapy induced peripheral neuropathy [CIPN] in patients diagnosed with a malignancy.
2010 · Janet Schloss, Maree Colosimo, et al.
[A case of breast tuberculosis].
1984 · A Alessi, E Nanni, et al. · PubMed
Works count: 8
Citation count: 512
H-index: 3
I10-index: 3
Year
Topic
Type